1. International retrospective natural history study of LMNA-related congenital muscular dystrophy
- Author
-
Ben Yaou, R, Yun, P, Dabaj, I, Norato, G, Donkervoort, S, Xiong, H, Nascimento, A, Maggi, L, Sarkozy, A, Monges, S, Bertoli, M, Komaki, H, Mayer, M, Mercuri, E, Zanoteli, E, Castiglioni, C, Marini-Bettolo, C, D'Amico, A, Deconinck, N, Desguerre, I, Erazo-Torricelli, R, Gurgel-Giannetti, J, Ishiyama, A, Kleinsteuber, KS, Lagrue, E, Laugel, V, Mercier, S, Messina, S, Politano, L, Ryan, MM, Sabouraud, P, Schara, U, Siciliano, G, Vercelli, L, Voit, T, Yoon, G, Alvarez, R, Muntoni, F, Pierson, TM, Gomez-Andres, D, Foley, AR, Quijano-Roy, S, Bonnemann, CG, Bonne, G, Ben Yaou, R, Yun, P, Dabaj, I, Norato, G, Donkervoort, S, Xiong, H, Nascimento, A, Maggi, L, Sarkozy, A, Monges, S, Bertoli, M, Komaki, H, Mayer, M, Mercuri, E, Zanoteli, E, Castiglioni, C, Marini-Bettolo, C, D'Amico, A, Deconinck, N, Desguerre, I, Erazo-Torricelli, R, Gurgel-Giannetti, J, Ishiyama, A, Kleinsteuber, KS, Lagrue, E, Laugel, V, Mercier, S, Messina, S, Politano, L, Ryan, MM, Sabouraud, P, Schara, U, Siciliano, G, Vercelli, L, Voit, T, Yoon, G, Alvarez, R, Muntoni, F, Pierson, TM, Gomez-Andres, D, Foley, AR, Quijano-Roy, S, Bonnemann, CG, and Bonne, G
- Abstract
Muscular dystrophies due to heterozygous pathogenic variants in LMNA gene cover a broad spectrum of clinical presentations and severity with an age of onset ranging from the neonatal period to adulthood. The natural history of these conditions is not well defined, particularly in patients with congenital or early onset who arguably present with the highest disease burden. Thus the definition of natural history endpoints along with clinically revelant outcome measures is essential to establishing both clinical care planning and clinical trial readiness for this patient group. We designed a large international cross-sectional retrospective natural history study of patients with genetically proven muscle laminopathy who presented with symptoms before two years of age intending to identify and characterize an optimal clinical trial cohort with pertinent motor, cardiac and respiratory endpoints. Quantitative statistics were used to evaluate associations between LMNA variants and distinct clinical events. The study included 151 patients (median age at symptom onset 0.9 years, range: 0.0-2.0). Age of onset and age of death were significantly lower in patients who never acquired independent ambulation compared to patients who achieved independent ambulation. Most of the patients acquired independent ambulation (n = 101, 66.9%), and subsequently lost this ability (n = 86; 85%). The age of ambulation acquisition (median: 1.2 years, range: 0.8-4.0) and age of ambulation loss (median: 7 years, range: 1.2-38.0) were significantly associated with the age of the first respiratory interventions and the first cardiac symptoms. Respiratory and gastrointestinal interventions occurred during first decade while cardiac interventions occurred later. Genotype-phenotype analysis showed that the most common mutation, p.Arg249Trp (20%), was significantly associated with a more severe disease course. This retrospective natural history study of early onset LMNA-related muscular dystrophy confi
- Published
- 2021